Dacomitinib in lung cancer: a “lost generation” EGFR tyrosine-kinase inhibitor from a bygone era?
Sai-Hong Ignatius Ou,1 Ross A Soo21Chao Family Comprehensive Cancer Center, Division of Hematology/Oncology, Department of Medicine, University of California, Irvine School of Medicine, Orange, CA, USA; 2National University Health System and Cancer Science Institute of Singapore, SingaporeA...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2015-10-01
|
| Series: | Drug Design, Development and Therapy |
| Online Access: | https://www.dovepress.com/dacomitinib-in-lung-cancer-a-ldquolost-generationrdquo-egfr-tyrosine-k-peer-reviewed-article-DDDT |